IVD Medical Holding Limited (HK:1931)
:1931
Want to see HK:1931 full AI Analyst Report?
1931 Stock Chart & Stats
HK$3.85
HK$0.05(2.67%)
At close: 4:00 PM EST
HK$3.85
HK$0.05(2.67%)
Day’s Range― - ―
52-Week RangeHK$0.69 - HK$12.86
Previous CloseN/A
Volume18.00K
Average Volume (3M)1.48M
Market Cap
HK$1.17B
Enterprise ValueHK$2.29B
Total Cash (Recent Filing)HK$551.05M
Total Debt (Recent Filing)HK$1.84B
Price to Earnings (P/E)28.4
Beta0.53
Next Earnings
Aug 14, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend Yield3.81%
Share Statistics
EPS (TTM)0.02
Shares Outstanding1,621,488,000
10 Day Avg. Volume1,443,300
30 Day Avg. Volume1,483,483
Financial Highlights & Ratios
PEG Ratio-1.25
Price to Book (P/B)1.29
Price to Sales (P/S)1.35
P/FCF Ratio-3.78
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Historic Margin StrengthA multi-year track record of healthy operating margins and positive growth from 2021–2024 indicates the company's distribution model and customer relationships achieved operational leverage. This history supports potential margin recovery and a durable revenue base if execution stabilizes.
Balance-sheet Equity BufferSizable equity and prior conservative leverage through 2020–2023 provide a meaningful capital buffer versus peers. That balance-sheet depth gives flexibility to absorb shocks, fund restructurings or working-capital swings without immediate solvency stress, supporting strategic options.
Low Market VolatilityA low beta (~0.51) signals lower sensitivity to market swings and suggests cash flows and earnings are less cyclical. For a medical-distribution firm, this aligns with steadier demand, which can reduce financing costs and investor pressure, aiding medium-term operational planning.
Bears Say
Revenue And Margin DeteriorationAn ~11% revenue decline and collapse of net margin to ~1.2% in 2025 reflect a structural earnings reset. Persistent margin erosion implies weaker pricing power or higher cost base, reducing cash generation and the company's ability to reinvest, service debt, or restore prior returns.
Severe Cash-flow WeaknessOperating cash flow swung to roughly -919M and free cash flow to -1.01B in 2025, signaling acute working-capital strain or elevated cash outlays. Such negative cash conversion undermines self-funding, raises liquidity risk, and likely forces reliance on external financing absent quick operational fixes.
Rising Financial LeverageDebt-to-equity rising to ~0.62 from ~0.20 materially increases financial leverage. Higher leverage magnifies earnings volatility, raises interest burden, and constrains strategic flexibility; combined with weak cash flow, it heightens refinancing and solvency risk over the coming months.
IVD Medical Holding Limited News
1931 FAQ
What was IVD Medical Holding Limited’s price range in the past 12 months?
IVD Medical Holding Limited lowest stock price was HK$0.69 and its highest was HK$12.86 in the past 12 months.
What is IVD Medical Holding Limited’s market cap?
IVD Medical Holding Limited’s market cap is HK$1.17B.
When is IVD Medical Holding Limited’s upcoming earnings report date?
IVD Medical Holding Limited’s upcoming earnings report date is Aug 14, 2026 which is in 71 days.
How were IVD Medical Holding Limited’s earnings last quarter?
IVD Medical Holding Limited released its earnings results on Mar 27, 2026. The company reported -HK$0.003 earnings per share for the quarter, missing the consensus estimate of N/A by -HK$0.003.
Is IVD Medical Holding Limited overvalued?
According to Wall Street analysts IVD Medical Holding Limited’s price is currently Overvalued.
Does IVD Medical Holding Limited pay dividends?
IVD Medical Holding Limited pays a Notavailable dividend of HK$0.062 which represents an annual dividend yield of 3.81%. See more information on IVD Medical Holding Limited dividends here
What is IVD Medical Holding Limited’s EPS estimate?
IVD Medical Holding Limited’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does IVD Medical Holding Limited have?
IVD Medical Holding Limited has 1,621,488,000 shares outstanding.
What happened to IVD Medical Holding Limited’s price movement after its last earnings report?
IVD Medical Holding Limited reported an EPS of -HK$0.003 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -0.893%.
Which hedge fund is a major shareholder of IVD Medical Holding Limited?
Currently, no hedge funds are holding shares in HK:1931
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
IVD Medical Holding Limited Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Positive
20 days / 200 days
Momentum
320.00%
12-Months-Change
Fundamentals
Return on Equity
1.09%
Trailing 12-Months
Asset Growth
12.45%
Trailing 12-Months
Company Description
IVD Medical Holding Limited
IVD Medical Holding Limited, an investment holding company, distributes In vitro diagnostic (IVD) products in Mainland China and internationally. The company operates through three segments: Distribution Business, Maintenance Services, and Self-branded Products Business. It offers IVD analysers, reagents, and other consumables for various IVD testing categories, including hematology and body fluid, immunoassay, clinical chemistry, molecular, microbiology, and point-of-care testing. The company also provides haemostasis products; solution services to the clinical laboratories of hospitals; and maintenance services, such as maintenance and repair, installation, and end customer training services. In addition, it researches, develops, manufactures, and sells IVD analyzers and reagents under the IVD brand. The company offers its products to hospitals and healthcare institutions, logistics providers, and distributors. IVD Medical Holding Limited was founded in 1993 and is headquartered in Shanghai, the People's Republic of China.
Technical Analysis
China Health Group
―
Shanghai Pharmaceuticals Holding Co
―
Sinopharm Group Co
―
Medlive Technology Co., Ltd.
―
Charmacy Pharmaceutical Co., Ltd. Class H
―
Options Prices
Currently, No data available
---